Insight Molecular Diagnostics (IMDX) Profit After Tax (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Profit After Tax of -$4.3 million for Q1 2026, up 81.31% sequentially from -$23.0 million in Q4 2025, and up 35.69% YoY from -$3.2 million in Q1 2025.
Insight Molecular Diagnostics (IMDX) Profit After Tax (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 12 years of Profit After Tax data on file, last reported at -$4.3 million in Q1 2026.
- Quarterly Profit After Tax rose 35.69% year-over-year to -$4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$47.8 million (up 17.81% YoY) and the FY2025 annual result came in at -$50.2 million, up 17.21% from the prior year.
- Profit After Tax advanced to -$4.3 million in Q1 2026 per IMDX's latest filing, from -$23.0 million in the prior quarter.
- The five-year high for Profit After Tax was $6.0 million in Q1 2023, with the low at -$45.0 million in Q4 2022.
- Average Profit After Tax over 5 years is -$12.5 million, with a median of -$9.3 million recorded in 2022.
- Year-over-year, Profit After Tax jumped 157.9% in 2023 and plunged 253.2% in 2024.
- Insight Molecular Diagnostics' Profit After Tax stood at -$45.0 million in 2022, then surged by 64.44% to -$16.0 million in 2023, then tumbled by 109.55% to -$33.5 million in 2024, then jumped by 31.5% to -$23.0 million in 2025, then surged by 81.31% to -$4.3 million in 2026.
- Business Quant data shows IMDX's Profit After Tax at -$4.3 million in Q1 2026, -$23.0 million in Q4 2025, and -$10.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.09 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | -4.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.29 Mn |
| Dec 31, 2025 | -22.96 Mn |
| Sep 30, 2025 | -10.85 Mn |
| Jun 30, 2025 | -9.74 Mn |
| Mar 31, 2025 | -6.67 Mn |
| Dec 31, 2024 | -33.51 Mn |
| Sep 30, 2024 | -13.49 Mn |
| Jun 30, 2024 | -4.53 Mn |
| Mar 31, 2024 | -9.13 Mn |
| Dec 31, 2023 | -15.99 Mn |
| Sep 30, 2023 | -6.49 Mn |
| Jun 30, 2023 | -8.33 Mn |
| Mar 31, 2023 | 5.96 Mn |
| Dec 31, 2022 | -44.98 Mn |
| Sep 30, 2022 | -9.33 Mn |
| Jun 30, 2022 | -8.30 Mn |
| Mar 31, 2022 | -10.29 Mn |
| Dec 31, 2021 | -35.89 Mn |
| Sep 30, 2021 | -13.80 Mn |
| Jun 30, 2021 | -10.49 Mn |